Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01243
|
|||||
Drug Name |
N-acetylaspartylglutamate
|
|||||
Synonyms |
NAAG; isospaglumic acid; spaglumic acid
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Vernal Keratoconjunctivitis [ICD11: 9A60.5] | Phase 4 | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C11H16N2O8
|
|||||
Canonical SMILES |
CC(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)O
|
|||||
InChI |
InChI=1S/C11H16N2O8/c1-5(14)12-7(4-9(17)18)10(19)13-6(11(20)21)2-3-8(15)16/h6-7H,2-4H2,1H3,(H,12,14)(H,13,19)(H,15,16)(H,17,18)(H,20,21)/t6-,7-/m0/s1
|
|||||
InChIKey |
OPVPGKGADVGKTG-BQBZGAKWSA-N
|
|||||
CAS Number |
CAS 3106-85-2
|
|||||
Pharmaceutical Properties | Molecular Weight | 304.25 | Topological Polar Surface Area | 170 | ||
Heavy Atom Count | 21 | Rotatable Bond Count | 9 | |||
Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 8 | |||
XLogP |
-2.1
|
|||||
PubChem CID | ||||||
PubChem SID |
103913863
, 104171316
, 10669851
, 11112559
, 11113480
, 11335837
, 113444559
, 11361076
, 11363293
, 11365855
, 11368417
, 11371698
, 11374703
, 11376579
, 11462048
, 11467119
, 11468239
, 11485238
, 11486787
, 11489387
, 11490575
, 11492688
, 11494213
, 11537717
, 124636732
, 124882459
, 128844339
, 135651520
, 136930122
, 142202893
, 144075620
, 14825413
, 162222804
, 164174696
, 26612503
, 26680122
, 26751698
, 33510452
, 47216778
, 47216779
, 47736484
, 47810759
, 47959745
, 76680351
, 7980673
, 8150014
, 85182292
, 91011602
, 92126028
, 99301750
|
|||||
ChEBI ID |
CHEBI:73688
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | AST | Transporter Info | Vesicular H(+)/Aspartate-glutamate cotransporter | Substrate | [2] | |
PEPT1 | Transporter Info | Peptide transporter 1 | Substrate | [3] | ||
Drug-Transporter Activity Data | ||||||
Drug-Transporter Activity Data | AST | Transporter Info | Km = 200 microM | Proteoliposomes-Sialin | [2] | |
References | ||||||
1 | ClinicalTrials.gov (NCT00357019) Study of the Clinical and Biological Efficacity of NAAXIA SINE in Vernal Keratoconjunctivitis | |||||
2 | Vesicular uptake of N-acetylaspartylglutamate is catalysed by sialin (SLC17A5). Biochem J. 2013 Aug 15;454(1):31-8. | |||||
3 | Molecular interactions between dipeptides, drugs and the human intestinal H+ -oligopeptide cotransporter hPEPT1. J Physiol. 2006 Jul 1;574(Pt 1):149-66. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.